Analyzing Adherence to the 2016 Infectious Diseases Society of America Guidelines for Candidemia in Cancer Patients.
Dena M LehmannNina CohenI-Hsin LinShane AlexanderRitu KathuriaMarina KerpelevYing TaurSusan K SeoPublished in: Open forum infectious diseases (2022)
The addition of MALDI-TOF did not shorten time to effective antifungal therapy. Nearly all patients were seen by ID for candidemia. Poor cancer prognosis was a common factor for incomplete composite adherence to the 2016 IDSA candidiasis guidelines.
Keyphrases
- infectious diseases
- mass spectrometry
- end stage renal disease
- candida albicans
- chronic kidney disease
- ejection fraction
- newly diagnosed
- clinical practice
- prognostic factors
- papillary thyroid
- peritoneal dialysis
- ms ms
- stem cells
- type diabetes
- squamous cell carcinoma
- patient reported outcomes
- young adults
- glycemic control
- metabolic syndrome
- squamous cell
- weight loss
- patient reported
- childhood cancer
- smoking cessation